Skip to main content
Premium Trial:

Request an Annual Quote

Hershel Safer, Eric Eastman, Martin Hollenhorst, Klaus Sprockamp

Premium

Hershel Safer, formerly a research scientist at Tel Aviv-based Compugen, has been tapped to head the bioinformatics department at Zetiq Technologies, a Rehovot, Israel-based biotechnology company developing non-cytotoxic anti-cancer drugs.

 

Morphochem of Munich, Germany, has appointed Eric Eastman to the newly created position of president of Morphochem Inc. He will also run the company’s research facility in Monmouth Junction, NJ. Eastman was previously senior vice president and CTO at Gaithersburg, Md.-based Gene Logic, where he managed the company’s R&D activities and its technology portfolio.

 

Lion Biosciences said it has appointed Martin Hollenhorst as the company’s new CFO. Hollenhorst, who most recently worked as a freelance management consultant in Washington, DC, will join the Heidelberg, Germany-based company on April 1. Hollenhorst’s experiences include serving as CEO of ANN Systems ASA, a German-American software company. He replaces Lion’s former CFO Klaus Sprockamp, who was lost in the Sept. 11 attacks on the World Trade Center in NewYork.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.